Oscar Health, Inc. (OSCR) - Form 8-K Summary
Business Context and Reporting Period
Oscar Health, Inc. filed this Current Report on Form 8-K on July 22, 2025. The filing announces preliminary financial results for the second quarter of 2025 and includes a revision to the company's full-year 2025 outlook.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the attached press release (Exhibit 99.1), which is incorporated by reference but not reproduced in the provided text.
Material Changes
- Outlook Revision: The Company has revised its full-year 2025 financial outlook.
- Q2 2025 Results: Preliminary results for the second quarter were announced, though specific figures are not listed in this document.
Guidance, Outlook, and Risks
Management has updated its guidance for the full year 2025. The filing explicitly states that the information regarding results and outlook is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section, except as expressly set forth by specific reference in other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 22, 2025) for specific Q2 2025 revenue, net income, and adjusted EBITDA figures.
- Verify the specific details of the revised full-year 2025 guidance (e.g., revenue range, loss per share, or membership targets).
- Assess the reasons provided for the outlook revision to understand underlying operational or market drivers.
- Confirm if the preliminary results indicate any changes in membership growth or medical loss ratios compared to prior periods.